Comparing Effects of Transforming Growth Factor β1 on Microglia From Rat and Mouse: Transcriptional Profiles and

Starlee Lively1, Doris Lam1,2, Raymond Wong1,2

  • 1Krembil Research Institute, Genes and Development Division, University Health Network, Toronto, ON, Canada.

Insights

Rat and mouse microglia exhibit significant species-specific differences in their response to transforming growth factor β1 (TGFβ1), impacting gene expression and ion channel activity. These variations are crucial for understanding neuroinflammation and developing targeted therapies.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Transforming growth factor β1 (TGFβ1) is implicated in central nervous system (CNS) injuries and neuroinflammation, with microglia playing a key role.
  • TGFβ1 is proposed as a therapeutic agent for neuroinflammation, yet direct comparisons of rat and mouse microglial responses are scarce.
  • Understanding species-specific differences is vital for improving preclinical studies and advancing translational therapeutic development.

Purpose of the Study:

  • To investigate and compare the responses of rat and mouse microglia to TGFβ1 stimulation.
  • To analyze species-specific alterations in gene expression, cell morphology, proliferation, apoptosis, and potassium channel activity.

Main Methods:

  • Isolation and treatment of microglia from Sprague-Dawley rats and C57BL/6 mice with TGFβ1.
  • Quantification of gene expression changes (>50 genes), microglial morphology, proliferation, and apoptosis.
  • Assessment of Kv1.3, Kir2.1, and KCa3.1 potassium channel expression and function.

Main Results:

  • Significant species-specific differences observed in gene expression, with some genes responding only in one species or showing opposite responses.
  • TGFβ1 influenced microglial morphology and proliferation in rats but not in mice; no apoptosis was observed in either species.
  • TGFβ1 increased Kv1.3 channel expression and current in both species, but induced opposite effects on KCa3.1 currents, with distinct responses compared to IL-10.

Conclusions:

  • Rat and mouse microglia display numerous, significant differences in their molecular and functional responses to TGFβ1.
  • These species-specific variations necessitate careful consideration in the characterization of neuroinflammation and microglial activation.
  • The findings highlight the importance of accounting for species differences when developing therapeutic strategies targeting microglia and potassium channels.

Related Concept Videos

Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.9K
Transcription Elongation Factors02:35

Transcription Elongation Factors

Transcription elongation is a dynamic process that alters depending upon the sequence heterogeneity of the DNA being transcribed. Hence, it is not surprising that the elongation complex's composition also varies along the way while transcribing a gene.
The transcription elongation is regulated via pausing of RNA polymerase on several occasions during transcription. In bacteria, these halts are necessary because the transcription of DNA into mRNA is coupled to the translation of that mRNA...
14.1K
Transcription Elongation Factors02:35

Transcription Elongation Factors

4.8K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
7.1K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
705
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.5K